The Business Research Company’s report on the Small Animal Imaging (In-Vivo) Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How have key drivers contributed to the rapid growth of the small animal imaging (in-vivo) market?
Growing expenditure in the healthcare sector is expected to propel the growth of the small animal imaging (in vivo) market going forward. Healthcare expenditure refers to the overall cost of health care (including public and private expenditures) as a percentage of GDP. Rising healthcare expenditure and increasing healthcare awareness encourage the concept of self-care management, where PET equipment is used in techniques such as small animal imaging. For instance, in May 2024, the Office for National Statistics, a UK-based statistics authority, reported that healthcare spending in the UK increased by 5.6% in nominal terms in 2023, with long-term health and social care expenditure increasing by 2.8% in real terms in 2022. Therefore, growing expenditure for the healthcare sector is driving the growth of the small animal imaging (in-vivo) market.
Access Your Free Sample of the Global Small Animal Imaging (In-Vivo) Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=7303&type=smp
How has the small animal imaging (in-vivo) market size evolved, and what are the latest forecasts for its expansion?
The small animal imaging (in-vivo) market size has grown rapidly in recent years. It will grow from $2.84 billion in 2024 to $3.17 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to preclinical research and drug development, expansion of pharmaceutical and biotechnology sectors, growth in translational research, disease modeling and pathophysiology studies, academic and government funding for research.
The small animal imaging (in-vivo) market size is expected to see rapid growth in the next few years. It will grow to $5.05 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to development of novel imaging probes and tracers, expansion of preclinical CROs (contract research organizations), integration of ai in image analysis, advanced multimodal imaging systems, 3D and high-resolution imaging for small animals, rise in research for rare and orphan diseases. Major trends in the forecast period include molecular and functional imaging in small animals, longitudinal and real-time in-vivo imaging, hybrid imaging modalities for multimodal information, imaging of CRISPR-edited animals for genetics research, AI-driven phenotyping and biomarker discovery, imaging for neurodegenerative diseases and neuroscience.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=7303&type=smp
Which major companies dominate the small animal imaging (in-vivo) market?
Major companies operating in the small animal imaging (In-Vivo) market include Bruker Corporation, PerkinElmer Inc., Miltenyi Biotec GmbH, Aspect Imaging Ltd., Mediso Ltd., Siemens AG, Life Technologies Corporation, Promega Corporation, Berthold Technologies GmbH and Co. KG, Spectral Instruments Imaging LLC, Agilent Technologies Inc., Bioscan Inc., Gamma Medica-Ideas Inc., Genovis AB, LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc.
What trends will shape the future of the sludge dewatering equipment market?
Technological advancement is a key trend gaining popularity in the small animal imaging (in-vivo) market. Major companies operating in the small animal imaging (in vivo) market are focused on technological advancement to strengthen their position. For instance, in April 2022, PerkinElmer, Inc., a US-based company engaged in business areas such as diagnostics, life science research, and imaging, launched the Vega imaging system, an automated advanced technology ultrasound platform. Automated technology involves the use of two automated transducers, resulting in easy-to-use technology and generating more consistent results to visualize the pathophysiology of the disease.
Which region dominates the small animal imaging (in-vivo) market, and what factors contribute to its leadership?
North America was the largest region in the small animal imaging (in-vivo) market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the small animal imaging (in-vivo) market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report
How is the small animal imaging (in-vivo) market segmented, and which segment holds the largest share?
The small animal imaging (In-Vivo) market covered in this report is segmented –
1) By Component: Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components
2) By Application: Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics
3) By End User: Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers
Subsegments:
1) By Micro-MRI: High-Field Micro-MRI Systems, Low-Field Micro-MRI Systems, MRI Contrast Agents
2) By Optical Imaging: In Vivo Fluorescence Imaging Systems, Bioluminescence Imaging Systems, Optical Coherence Tomography Systems
3) By Nuclear Imaging: Positron Emission Tomography (PET) Scanners, Single Photon Emission Computed Tomography (SPECT) Systems, Radioactive Tracers
4) By Other Components: X-Ray Imaging Systems, CT Imaging Systems, Ultrasound Imaging Systems
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7303
How is the small animal imaging (in-vivo) market defined?
Small animal imaging (in vivo) refers to the advanced imaging techniques for monitoring cellular activity, pharmacological effects that have been developed, and disease progression in live animals. Small animal imaging (in vivo) is used to observe, define, and quantify normal and pathologic processes in living animal organs and tissues non-invasively.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
